Comparative Pharmacology
Head-to-head clinical analysis: PHENERGAN VC W CODEINE versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHENERGAN VC W CODEINE versus QOLIANA.
PHENERGAN VC W/ CODEINE vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Phenergan VC w/ Codeine combines codeine (opioid agonist, mu-receptor), promethazine (histamine H1 antagonist, anticholinergic, sedative), and phenylephrine (alpha-1 adrenergic agonist). Codeine is metabolized to morphine for analgesia and antitussive effects; promethazine suppresses cough via central nervous system depression; phenylephrine causes vasoconstriction to relieve congestion.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
1 to 2 teaspoonfuls (5-10 mL) orally every 4 to 6 hours as needed. Maximum 4 doses in 24 hours.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Codeine: terminal half-life ~3 hours (range 2.5-4.5 h) in adults; extended in renal impairment. Promethazine: terminal half-life ~10-14 hours (range 7-20 h) in adults; prolonged in elderly and hepatic impairment.
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Codeine: renal elimination of metabolites (codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide, morphine-6-glucuronide); ~90% excreted in urine, <10% in feces. Promethazine: renal and biliary elimination as metabolites and unchanged drug; ~70-80% in urine, <20% in feces.
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist